Literature DB >> 17540336

Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants.

Stefaan Sansen1, Mei-Hui Hsu, C David Stout, Eric F Johnson.   

Abstract

Human P450 2A6 displays a small active site that is well adapted for the oxidation of small planar substrates. Mutagenesis of CYP2A6 resulted in an increased catalytic efficiency for indole biotransformation to pigments and conferred a capacity to oxidize substituted indoles (Wu, Z.-L., Podust, L.M., Guengerich, F.P. J. Biol. Chem. 49 (2005) 41090-41100.). Here, we describe the structural basis that underlies the altered metabolic profile of three mutant enzymes, P450 2A6 N297Q, L240C/N297Q and N297Q/I300V. The Asn297 substitution abolishes a potential hydrogen bonding interaction with substrates in the active site, and replaces a structural water molecule between the helix B'-C region and helix I while maintaining structural hydrogen bonding interactions. The structures of the P450 2A6 N297Q/L240C and N297Q/I300V mutants provide clues as to how the protein can adapt to fit the larger substituted indoles in the active site, and enable a comparison with other P450 family 2 enzymes for which the residue at the equivalent position was seen to function in isozyme specificity, structural integrity and protein flexibility.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540336      PMCID: PMC2773796          DOI: 10.1016/j.abb.2007.04.028

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  39 in total

1.  Random mutagenesis of human cytochrome p450 2A6 and screening with indole oxidation products.

Authors:  K Nakamura; M V Martin; F P Guengerich
Journal:  Arch Biochem Biophys       Date:  2001-11-01       Impact factor: 4.013

2.  Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.

Authors:  K Ikeda; K Yoshisue; E Matsushima; S Nagayama; K Kobayashi; C A Tyson; K Chiba; Y Kawaguchi
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

3.  Identification and characterisation of novel polymorphisms in the CYP2A locus: implications for nicotine metabolism.

Authors:  M Oscarson; R A McLellan; H Gullstén; J A Agúndez; J Benítez; A Rautio; H Raunio; O Pelkonen; M Ingelman-Sundberg
Journal:  FEBS Lett       Date:  1999-10-29       Impact factor: 4.124

4.  Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases.

Authors:  R Hoessel; S Leclerc; J A Endicott; M E Nobel; A Lawrie; P Tunnah; M Leost; E Damiens; D Marie; D Marko; E Niederberger; W Tang; G Eisenbrand; L Meijer
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

5.  The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins.

Authors:  T L Domanski; Y Q He; E E Scott; Q Wang; J R Halpert
Journal:  Arch Biochem Biophys       Date:  2001-10-01       Impact factor: 4.013

6.  Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?

Authors:  S Leclerc; M Garnier; R Hoessel; D Marko; J A Bibb; G L Snyder; P Greengard; J Biernat; Y Z Wu; E M Mandelkow; G Eisenbrand; L Meijer
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

7.  A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.

Authors:  Sam P de Visser; Sason Shaik
Journal:  J Am Chem Soc       Date:  2003-06-18       Impact factor: 15.419

8.  Predicting the mutagenicity of tobacco-related N-nitrosamines in humans using 11 strains of Salmonella typhimurium YG7108, each coexpressing a form of human cytochrome P450 along with NADPH-cytochrome P450 reductase.

Authors:  K Fujita; T Kamataki
Journal:  Environ Mol Mutagen       Date:  2001       Impact factor: 3.216

9.  Diversity in the oxidation of substrates by cytochrome P450 2D6: lack of an obligatory role of aspartate 301-substrate electrostatic bonding.

Authors:  F Peter Guengerich; Grover P Miller; Imad H Hanna; Martha V Martin; Serge Léger; Cameron Black; Nathalie Chauret; José M Silva; Laird A Trimble; James A Yergey; Deborah A Nicoll-Griffith
Journal:  Biochemistry       Date:  2002-09-10       Impact factor: 3.162

10.  Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity.

Authors:  P A Williams; J Cosme; V Sridhar; E F Johnson; D E McRee
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

View more
  19 in total

Review 1.  Substrate binding to cytochromes P450.

Authors:  Emre M Isin; F Peter Guengerich
Journal:  Anal Bioanal Chem       Date:  2008-07-13       Impact factor: 4.142

2.  Oxidation of Acenaphthene and Acenaphthylene by Human Cytochrome P450 Enzymes.

Authors:  Tsutomu Shimada; Shigeo Takenaka; Norie Murayama; Hiroshi Yamazaki; Joo-Hwan Kim; Donghak Kim; Francis K Yoshimoto; F Peter Guengerich; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2015-02-16       Impact factor: 3.739

3.  Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.

Authors:  Tsutomu Shimada; Norie Murayama; Katsuhiro Tanaka; Shigeo Takenaka; F Peter Guengerich; Hiroshi Yamazaki; Masayuki Komori
Journal:  Chem Res Toxicol       Date:  2011-07-20       Impact factor: 3.739

4.  X-ray crystal structure of the cytochrome P450 2B4 active site mutant F297A in complex with clopidogrel: insights into compensatory rearrangements of the binding pocket.

Authors:  Manish B Shah; Hyun-Hee Jang; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2013-01-04       Impact factor: 4.013

5.  Conformational Response of N-Terminally Truncated Cytochrome P450 3A4 to Ligand Binding in Solution.

Authors:  Shih-Wei Chuo; Shu-Hao Liou; Lee-Ping Wang; R David Britt; Thomas L Poulos; Irina F Sevrioukova; David B Goodin
Journal:  Biochemistry       Date:  2019-09-06       Impact factor: 3.162

6.  Effect of CYP2A13 active site mutation N297A on metabolism of coumarin and tobacco-specific nitrosamines.

Authors:  Kari E Schlicht; Jeannette Zinggeler Berg; Sharon E Murphy
Journal:  Drug Metab Dispos       Date:  2008-12-12       Impact factor: 3.922

7.  Roles of Human CYP2A6 and Monkey CYP2A24 and 2A26 Cytochrome P450 Enzymes in the Oxidation of 2,5,2',5'-Tetrachlorobiphenyl.

Authors:  Tsutomu Shimada; Kensaku Kakimoto; Shigeo Takenaka; Nobuyuki Koga; Shotaro Uehara; Norie Murayama; Hiroshi Yamazaki; Donghak Kim; F Peter Guengerich; Masayuki Komori
Journal:  Drug Metab Dispos       Date:  2016-09-13       Impact factor: 3.922

8.  Directed evolution reveals requisite sequence elements in the functional expression of P450 2F1 in Escherichia coli.

Authors:  James B Y H Behrendorff; Chad D Moore; Keon-Hee Kim; Dae-Hwan Kim; Christopher A Smith; Wayne A Johnston; Chul-Ho Yun; Garold S Yost; Elizabeth M J Gillam
Journal:  Chem Res Toxicol       Date:  2012-08-29       Impact factor: 3.739

9.  Identification of amino acid residues involved in 4-chloroindole 3-hydroxylation by cytochrome P450 2A6 using screening of random libraries.

Authors:  Zhi-Gang Zhang; Yan Liu; F Peter Guengerich; Johannes H Matse; Jun Chen; Zhong-Liu Wu
Journal:  J Biotechnol       Date:  2008-10-15       Impact factor: 3.307

10.  Development of a new predictive model for interactions with human cytochrome P450 2A6 using pharmacophore ensemble/support vector machine (PhE/SVM) approach.

Authors:  Max K Leong; Yen-Ming Chen; Hong-Bin Chen; Po-Hong Chen
Journal:  Pharm Res       Date:  2008-12-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.